116 related articles for article (PubMed ID: 9396697)
21. Chemical structure of a polysaccharide from Campylobacter jejuni 176.83 (serotype O:41) containing only furanose sugars.
Hanniffy OM; Shashkov AS; Moran AP; Prendergast MM; Senchenkova SN; Knirel YA; Savage AV
Carbohydr Res; 1999 Jun; 319(1-4):124-32. PubMed ID: 10520260
[TBL] [Abstract][Full Text] [Related]
22. [Polyradiculoneuritis and Campylobacter jejuni: clinical and physiopathological aspects].
Diagana M; Khalil M; Preux PM; Dumas M; Jauberteau MO
Med Trop (Mars); 2003; 63(1):68-74. PubMed ID: 12891754
[TBL] [Abstract][Full Text] [Related]
23. Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.
Prendergast MM; Kosunen TU; Moran AP
J Clin Microbiol; 2001 Apr; 39(4):1494-500. PubMed ID: 11283076
[TBL] [Abstract][Full Text] [Related]
24. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
[TBL] [Abstract][Full Text] [Related]
25. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome.
Yuki N; Taki T; Takahashi M; Saito K; Yoshino H; Tai T; Handa S; Miyatake T
Ann Neurol; 1994 Nov; 36(5):791-3. PubMed ID: 7526777
[TBL] [Abstract][Full Text] [Related]
26. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
Perera VN; Nachamkin I; Ung H; Patterson JH; McConville MJ; Coloe PJ; Fry BN
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):27-36. PubMed ID: 17374131
[TBL] [Abstract][Full Text] [Related]
27. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
[TBL] [Abstract][Full Text] [Related]
28. Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures.
Moran AP
FEMS Immunol Med Microbiol; 1995 Apr; 11(2):121-30. PubMed ID: 7640672
[TBL] [Abstract][Full Text] [Related]
29. The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168.
St Michael F; Szymanski CM; Li J; Chan KH; Khieu NH; Larocque S; Wakarchuk WW; Brisson JR; Monteiro MA
Eur J Biochem; 2002 Nov; 269(21):5119-36. PubMed ID: 12392544
[TBL] [Abstract][Full Text] [Related]
30. [Campylobacter jejuni colitis and Guillain-Barre syndrome].
Fujimoto S
Fukuoka Igaku Zasshi; 1998 May; 89(5):127-32. PubMed ID: 9642872
[No Abstract] [Full Text] [Related]
31. [Guillain-Barré syndrome].
Yuki N
Nihon Rinsho; 1994 Nov; 52(11):2952-8. PubMed ID: 7996693
[TBL] [Abstract][Full Text] [Related]
32. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
[TBL] [Abstract][Full Text] [Related]
33. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
Lastovica AJ; Goddard EA; Argent AC
J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
[TBL] [Abstract][Full Text] [Related]
34. The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni.
Moran AP
Subcell Biochem; 2010; 53():209-40. PubMed ID: 20593269
[TBL] [Abstract][Full Text] [Related]
35. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide.
Aspinall GO; McDonald AG; Raju TS; Pang H; Kurjanczyk LA; Penner JL; Moran AP
Eur J Biochem; 1993 May; 213(3):1029-37. PubMed ID: 8504799
[TBL] [Abstract][Full Text] [Related]
36. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
[TBL] [Abstract][Full Text] [Related]
37. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
[No Abstract] [Full Text] [Related]
38. [Structure and properties of the lipopolysaccharide of Pseudomonas fluorescens IMV 2366 (biovar III)].
Veremeĭchenko SN; Zdorovenko GM
Mikrobiologiia; 2004; 73(3):312-9. PubMed ID: 15315223
[TBL] [Abstract][Full Text] [Related]
39. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
[TBL] [Abstract][Full Text] [Related]
40. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.
Yuki N; Taki T; Inagaki F; Kasama T; Takahashi M; Saito K; Handa S; Miyatake T
J Exp Med; 1993 Nov; 178(5):1771-5. PubMed ID: 8228822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
